---

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

---

 

FORM 8-K

 

---

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): May 11, 2004

 

---

 

COVALENT GROUP, INC.

(Exact name of issuer as specified in charter)

 

---

 

DELAWARE		0-21145		56-1668867
(State or Other Jurisdiction of Incorporation or Organization)		(Commission file number)		(I.R.S. Employer Identification Number)

 

One Glenhardie Corporate Center

1275 Drummers Lane

Suite 100

Wayne, Pennsylvania 19087

(Address of principal executive offices)

 

(610) 975-9533

(Registrant’s telephone number, including area code)

 

---

---

Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.

 

(c)

Exhibits

 

Exhibit No.		Description
99.1		Covalent Group, Inc. Press Release dated May 11, 2004

 

Item 12. Results of Operations and Financial Condition.

 

On May 11, 2004, Covalent Group, Inc. issued a press release reporting its financial results for the first quarter ended March 31, 2004. A copy of the press release is attached as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference.

 

The information in this report shall not be treated as “filed” for purposes of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.

---

Signatures

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

		COVALENT GROUP, INC.
Date: May 12, 2004		By:		/s/ Kenneth M. Borow, M.D.
				Kenneth M. Borow, M.D.
				President and Chief Executive Officer

---

Index to Exhibits

 

Exhibit No.		Description
99.1		Covalent Group, Inc. Press Release dated May 11, 2004